{
  "author": "phrenikos",
  "the_new_excerpt": "Let me know if you can find a more undervalued Biotech play. Uplisting to NASDAQ\ntomorrow.\n\nIPA is a global technology platform company with end-to-end solutions empowering\ncompanies to discover and develop therapies against any disease. The Company's\nexperience and cutting-edge technologies enable…",
  "original_created_utc": 1609281928,
  "localize": [
    {
      "locale": "zh",
      "the_new_excerpt": "如果你能找到一个价值更低的生物科技公司，请告诉我。正在升级到纳斯达克(NASDAQ)\n明天。\n\nIPA是一家全球技术平台公司，提供端到端解决方案\n公司发现和开发针对任何疾病的治疗方法。本公司的\n经验和尖端技术使…",
      "title": "IPA-Immunoprecise Ab Ltd-可能是纳斯达克最被低估的生物技术业务"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "如果你能找到一個價值更低的生物科技公司，請告訴我。正在升級到納斯達克(NASDAQ)\n明天。\n\nIPA是一家全球技術平臺公司，提供端到端解決方案\n公司發現和開發針對任何疾病的治療方法。本公司的\n經驗和尖端技術使…",
      "title": "IPA-Immunoprecise Ab Ltd-可能是納斯達克最被低估的生物技術業務"
    }
  ],
  "title": "IPA - Immunoprecise Antibodies LTD - Probably the most undervalued Biotech play going to the NASDAQ",
  "created_utc": 1609327950,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>Let me know if you can find a more undervalued Biotech play. Uplisting to NASDAQ tomorrow.</p>\n\n<p>IPA is a global technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. The Company&#39;s experience and cutting-edge technologies enable unparalleled support of its partners in their quest to bring innovative treatments to the clinic. IPA&#39;s full-service capabilities dramatically reduce the time required for, and the inherent risk associated with, conventional multi-vendor product development.</p>\n\n<p><a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=3021397-1&amp;h=1538890274&amp;u=http%3A%2F%2Fwww.immunoprecise.com%2F&amp;a=www.immunoprecise.com\">www.immunoprecise.com</a></p>\n\n<p>&#x200B;</p>\n\n<p>- First of all, this company is a COVID mutation stock similar to ABCL (the catch: ABCL is a 10 billion dollar company and IPA is a 300 million dollar company) Their cocktail therapy approach is designed to be effective against more than one virus strain.</p>\n\n<p>-CEO Jennifer Bath sits on the advisory board for the WHO </p>\n\n<p>- Even without the COVID therapy, this company is generating revenue through its CRO lab research services  which are growing at 50% yoy, with beautiful margins and a positive EBITDA. Just reported a 4.7m rev quarter with 700k ebitda.</p>\n\n<p>- EXTREMELY low float. insiders have 1.5m shares. if we subtract that from the outstanding its about 15m shares. Uplist will allow IPA to find more institutional investors and lock up the float even more. Barely any warrants outstanding as welll. this company is looking to raise money at a much higher market cap, with institutional investors likely as part of the raise. with this kind of float a few whales buying will make this stock explode</p>\n\n<p>- Solid balance sheet with 17m of cash and barely any debt</p>\n\n<p>- Check out the corporate presentation for the antibody pipeline. Lots of irons in the fire. Partnerships with massive companies like JNJ, GMAB, TWST and organizations like the NIH</p>\n\n<p>- One of the fastest growing companies on Deloitte list: <a href=\"https://www.newswire.ca/news-releases/immunoprecise-antibodies-ranked-number-240-fastest-growing-company-in-north-america-on-deloitte-s-2020-technology-fast-500-tm--856367721.html\">https://www.newswire.ca/news-releases/immunoprecise-antibodies-ranked-number-240-fastest-growing-company-in-north-america-on-deloitte-s-2020-technology-fast-500-tm--856367721.html</a></p>\n\n<p>-Also has an at home Covid 19 test: <a href=\"https://www.prnewswire.com/news-releases/ipa-delivers-lead-candidate-antibodies-from-b-cell-select-platform-for-at-home-sars-cov-2-diagnostic-test-301148321.html\">https://www.prnewswire.com/news-releases/ipa-delivers-lead-candidate-antibodies-from-b-cell-select-platform-for-at-home-sars-cov-2-diagnostic-test-301148321.html</a></p>\n\n<p>&#x200B;</p>\n\n<p>Corporate Presentation</p>\n\n<p><a href=\"https://www.immunoprecise.com/wp-content/uploads/2020/12/IPA_Investor_Deck_Dec2020_v3.pdf\">https://www.immunoprecise.com/wp-content/uploads/2020/12/IPA_Investor_Deck_Dec2020_v3.pdf</a></p>\n\n<p>Video of CEO</p>\n\n<p><a href=\"https://www.bing.com/videos/search?q=bloomberg+jen+bath&amp;qs=PF&amp;cvid=e56cfa5804044109bcc105902943948b&amp;cc=CA&amp;setlang=en-US&amp;plvar=0&amp;ru=%2fsearch%3fq%3dbloomberg%2bjen%2bbath%26form%3dEDGEAR%26qs%3dPF%26cvid%3de56cfa5804044109bcc105902943948b%26cc%3dCA%26setlang%3den-US%26plvar%3d0&amp;view=detail&amp;mmscn=vwrc&amp;mid=EC0E19108C7EDC9E7E6AEC0E19108C7EDC9E7E6A&amp;FORM=WRVORC\">https://www.bing.com/videos/search?q=bloomberg+jen+bath&amp;qs=PF&amp;cvid=e56cfa5804044109bcc105902943948b&amp;cc=CA&amp;setlang=en-US&amp;plvar=0&amp;ru=%2fsearch%3fq%3dbloomberg%2bjen%2bbath%26form%3dEDGEAR%26qs%3dPF%26cvid%3de56cfa5804044109bcc105902943948b%26cc%3dCA%26setlang%3den-US%26plvar%3d0&amp;view=detail&amp;mmscn=vwrc&amp;mid=EC0E19108C7EDC9E7E6AEC0E19108C7EDC9E7E6A&amp;FORM=WRVORC</a></p>\n</div><!-- SC_ON -->",
  "score": 49,
  "permalink": "/r/stocks/comments/kmovwb/ipa_immunoprecise_antibodies_ltd_probably_the/",
  "subreddit": "stocks",
  "id": "kmovwb",
  "is_self": true,
  "media": null,
  "is_video": false,
  "source_updated_at": 1609495335775
}